Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sunesis Pharmaceuticals Inc (NASDAQ:SNSS)

1.97
Delayed Data
As of Oct 20
 -0.03 / -1.50%
Today’s Change
1.84
Today|||52-Week Range
4.45
-45.58%
Year-to-Date
No recent news for Sunesis Pharmaceuticals Inc.

Today’s Trading

Previous close2.00
Today’s open2.01
Day’s range1.95 - 2.01
Volume49,406
Average volume (3 months)146,189
Market cap$46.3M
Dividend yield--
Data as of 3:59pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)+19.33%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-17.15%
P/E ratioNM
Price/Sales22.39
Price/Book18.60

Competitors

 Today’s
change
Today’s
% change
EGLTEgalet Corp+0.01+0.95%
JNPJuniper Pharmaceutic...-0.05-1.09%
MBRXMoleculin Biotech In...-0.03-1.36%
CHMAChiasma Inc0.000.00%
Data as of 3:59pm ET, 10/20/2017

Financials

Next reporting dateNovember 2, 2017
EPS forecast (this quarter)-$0.39
Annual revenue (last year)$2.5M
Annual profit (last year)-$38.0M
Net profit margin-1,499.33%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO, Secretary &
Director
Daniel N. Swisher
Chief Scientific Officer
Judith A. Fox
Corporate headquarters
South San Francisco, California

Forecasts